Exclusive Interview with IFC's Nikunj Jinsi: Hospitals and Life Sciences Are Top Priorities in Healthcare Investment
The International Finance Corporation (hereinafter referred to as “IFC”), a member of the World Bank Group, is the world’s largest development institution focused on the private sector in developing countries. Established in 1956 and headquartered in Washington, D.C., USA, the IFC is committed to helping developing countries eradicate poverty and promote shared prosperity. Through extensive investments and collaborations across developing nations worldwide—spanning sectors such as financial markets, manufacturing, infrastructure, energy, healthcare, and education—the IFC has significantly improved people’s livelihoods and effectively fostered local economic development and prosperity.
Since its first investment project in China in 1985, the International Finance Corporation (IFC) has been extensively involved in China’s economic and social development through various means, including equity investments, loans, and advisory services. In the healthcare sector, the IFC has successfully invested in projects such as Fosun Pharma, Aier Eye Hospital, and Shandong Weigao, achieving strong financial returns while contributing to the advancement of China’s healthcare industry.
In recent years, with the rapid development of the internet, the Internet of Things (IoT), and biotechnology, IFC has increasingly prioritized investments in the healthcare sector, aiming to make new technologies more accessible to the general public. VCBeat(WeChat ID: vcbeat)An Exclusive Interview with Nikunj Jinsi, Global Head of IFC’s Venture Capital Business: Insights into IFC’s Healthcare Investment Philosophy, Achievements, and Future Plans, as Well as Its Strong Commitment to Supporting Chinese Enterprises in Accelerating Growth and Entering Global Emerging Markets – VCBeat(WeChat ID: vcbeat)We also hope to fully leverage the advantages of China’s leading healthcare venture capital service platform to facilitate extensive collaboration between IFC and Chinese healthcare innovation enterprises, thereby contributing to solving healthcare challenges in developing countries worldwide and improving the living standards of the general public.
Mr. Jin Nikun, Global Head of IFC’s Venture Capital Business
Jin Nikun told VCBeat (WeChat ID: vcbeat) that the IFC is not an investment institution purely pursuing financial returns, but a global development agency tasked with eliminating extreme poverty and promoting shared prosperity worldwide. Therefore, the goal of IFC’s healthcare investments is to ensure that every ordinary patient, whether in urban or rural areas, has access to timely, high-quality, and affordable medical services, thereby fostering positive development for local communities and individuals.
Fifteen years ago, the IFC established a dedicated healthcare and education investment division with the aim of promoting private investment in healthcare projects in developing countries. Today, as the largest multilateral investor in the private healthcare sector, the IFC no longer focuses solely on attractive projects; instead, it places greater emphasis on identifying long-term, like-minded partners to drive overall improvement in the healthcare systems of developing nations.
Jin Nikun told VCBeat(WeChat ID: vcbeat)In fiscal year 2015, the IFC’s total investment portfolio in healthcare services and life sciences reached $1.6 billion. Geographically, Asia received the largest share of investments, followed by Europe, Latin America, and Africa. By sector, hospitals accounted for the predominant share at 65%; life sciences represented 29%, while other sectors collectively made up the remaining 6%.
So, how exactly does the IFC approach healthcare investments? In Latin America and the Caribbean, where hospital projects are relatively scarce, the IFC has opted to strengthen hospitals’ physical infrastructure by expanding bed capacity, emergency departments, delivery rooms, and plastic surgery operating theaters, as well as procuring laboratory instruments. As a result, hospitals that previously suffered from inadequate medical equipment can now provide comprehensive healthcare services to patients. In the Dominican Republic and Mexico, the IFC has invested in companies dedicated to modern oncology services and introduced various types of equipment to hospitals through financial leasing, establishing interconnected radiotherapy centers across multiple hospitals.
In India, IFC invested in EYE-Q, an ophthalmic healthcare service provider that currently operates 28 eye care centers across the country and plans to expand its network to 45 centers by 2020.
In Kenya, the IFC has invested in Goodlife Pharmacy, a retail pharmaceutical company, with the aim of ultimately establishing a network of 80 retail pharmacies to ensure local residents have timely access to essential medications.
In addition to projects in medical services, the IFC places significant emphasis on investments in medical technology. In 2013, the IFC established a strategy for global investment in medical technology, focusing on two key aspects: first, technologies that can substantially reduce the incidence and mortality rates of major diseases while offering promising commercial returns; and second, ease of use, ensuring suitability for the inadequate infrastructure and human resource conditions prevalent in many developing countries.
In recent years, driven by new waves such as mobile internet, China has seen the emergence of numerous innovative enterprises and previously unseen business models. Jin Nikun noted that new technologies like mobile internet can significantly reduce healthcare costs and improve the accessibility of medical services, bringing substantial benefits to many underdeveloped and marginalized regions. This aligns closely with the International Finance Corporation’s (IFC) original intent in actively investing in the healthcare sector. Consequently, IFC is paying close attention to areas such as mobile health and aims to identify three to five suitable investment targets. Jin Nikun further believes that the many innovative companies and intriguing business models that have emerged in recent years will prove their viability through market validation, and that these entities may undergo large-scale mergers and acquisitions in the coming years.
With offices in 100 countries worldwide, partnerships with hundreds of financial institutions, and a portfolio of more than 2,000 private-sector clients, the IFC leverages its unique advantages to provide robust support for innovative enterprises expanding into global markets.
Jin Nikun told VCBeat(WeChat ID: vcbeat), IFC has been actively providing various forms of assistance to innovative enterprises, such as supporting their expansion into new markets, offering consulting and advisory services, introducing potential partners and M&A opportunities, and facilitating transactions.
Launched in January this year, the TechEmerge program is IFC’s latest initiative to help innovative healthcare companies enter emerging markets. Through TechEmerge, IFC aims to bring together cutting-edge medical innovation enterprises from around the world, connect them with the resources they need, and facilitate the introduction of their products or services into a wide range of developing countries, thereby effectively improving healthcare standards in these regions. In this process, IFC provides financial support to participating companies and assists in the local implementation of their projects.
The TechEmerge initiative primarily focuses on India’s healthcare system, with 18 locally accredited healthcare partners participating. Strategic partners such as Medtronic, Philips, and the Aditya Birla Group—one of India’s largest multinational conglomerates—are also involved in the project. The initiative attracted applications from over 300 companies; the selection phase has now concluded, and the International Finance Corporation (IFC) is actively assisting these companies with their market entry and operations in India.
Regarding the future of the TechEmerge project, Jin Nikun stated that this year’s event is merely a starting point and will be continued in the years to come. The geographic focus will expand beyond India, and Chinese healthcare innovation enterprises are warmly welcomed to participate.
In his final remarks to VCBeat (WeChat ID: vcbeat), Jin Nikun stated that, as a member of the International Finance Corporation (IFC), an international development institution, he firmly believes in the immense potential of the private sector to improve the efficiency of healthcare systems. He emphasized that companies can contribute to a better world by achieving sustainable development through profitability. Through his engagements with governments and clients worldwide, Jin has personally witnessed the rapid development of many countries, which has filled him with excitement and a strong sense of mission. Now, Jin hopes that more Chinese healthcare innovation enterprises will join this exciting endeavor, working alongside the IFC to promote prosperity and progress in developing countries.